Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo [Phase 2]

View source ↗

Summary

Phase 2 study evaluating INCB054707 for nonsegmental vitiligo has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonsegmental Vitiligo

Drugs mentioned

• INCB054707

Snippet

Sponsor: Incyte Corporation | Conditions: NonSegmental Vitiligo | Phase 2 | Status: COMPLETED | Results posted: 2023-07-05